ADOZX | GARIX | ADOZX / GARIX | |
Total Expense Ratio | 1.75 | 1.50 | 117% |
Annual Report Gross Expense Ratio | 1.75 | 1.72 | 102% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | 2.650 | 6.310 | 42% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 100000 | 500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 207M | 822M | 25% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 11.85 | -5.31 | -223% |
Returns for 3 years | 36.68 | 25.43 | 144% |
Returns for 5 years | 35.61 | 53.61 | 66% |
Returns for 10 years | 71.13 | 58.70 | 121% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRXCX | 14.98 | -0.17 | -1.12% |
MFS Blended Research Intl Eq C | |||
UEMPX | 8.42 | -0.11 | -1.29% |
UBS Emerging Markets Equity Opp P | |||
REREX | 57.41 | -0.78 | -1.34% |
American Funds EUPAC R4 | |||
FMGGX | 48.34 | -0.67 | -1.37% |
Franklin Small-Mid Cap Growth R6 | |||
CEFIX | 13.16 | -0.20 | -1.50% |
Calvert Emerging Markets Advancement I |